Genomic and metabolomic profiling reveals no single pathogenic lineage in Bacteroides fragilis infections
Investigators analyzed 813 Division I Bacteroides fragilis genomes, including 147 new clinical isolates, to determine the genetic drivers of extra-intestinal infections. The study found that infection-associated strains are phylogenetically dispersed across 16 distinct phylogroups, with no single pathogenic lineage, while mGWAS and metabolomic profiling identified 44 enriched genes and 12 metabolites linked to extra-intestinal isolation. These population-scale markers highlight lineage-specific capsule and competition loci, offering molecular diagnostics researchers new genomic and metabolic targets for strain differentiation and anaerobic infection surveillance.
The original study
Comparative genomic analysis of
- Authors
- Oles RE, Carrillo Terrrazas M, Loomis LR, Zuffa S, Neal MJ, Hsu C-Y, et al.
- Journal
- Microbiology spectrum
- Type
- Journal Article
- PMID
- 42446195
Original abstract
Bacteroides fragilis, a key member of the human gut microbiota, contributes to host health by maintaining intestinal homeostasis. Yet, it is also the most frequently isolated anaerobe in clinical infections. These contrasting roles raise questions about the genetic and ecological factors that explain why this common symbiont is disproportionately linked to infection. We analyzed 813 Division I B. fragilis genomes, including 147 new isolates from intestinal and extra-intestinal sites. Infection-associated isolates spanned all phylogroups, indicating no pathogenic lineage. We identified 16 phylogroups, distinguished by genes associated with capsule biosynthesis and interbacterial competition. Additionally, differential metabolomic analysis identified 12 metabolites associated with isolation source, while a microbial genome-wide association study uncovered 44 genes enriched in isolates from extra-intestinal sites, providing the first population-scale markers tied to clinical recovery sites. These results do not implicate a pathogenic lineage; instead, they point to associational links between accessory modules and recovery from extra-intestinal sites under permissive host conditions. This work underscores how genomic diversity and ecological context may jointly shape the clinical impact of gut commensals.IMPORTANCEBacteroides fragilis, a human gut resident, is paradoxically one of the most frequent anaerobes recovered from bloodstream and abscess infections. The genetic features that enable frequent recovery from extra-intestinal sites remain poorly defined. Using comparative genomic and metabolomic analyses of strains from intestinal and extra-intestinal sources, we show that strains isolated from infections are phylogenetically dispersed rather than restricted to a single lineage. We observe lineage-linked differences in capsule loci and competition systems, which suggests constrained gene flow and lineage-specific adaptation within the gut. Additionally, a subset of genes and metabolites is enriched among extra-intestinal isolates. Together, these findings suggest that extra-intestinal survival among B. fragilis strains reflects the interplay between species-wide genomic diversity and permissive host conditions, rather than the emergence of a single pathogenic lineage.